Report Summary
Eternity Insights has published a new study on Global Biopharmaceutical CMO & CRO Market focusing on key segments as by Type (Mammalian, Non-mammalian, Other), by Application (Contract Manufacturing, Contract Research, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Biopharmaceutical CMO & CRO Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Biopharmaceutical CMO & CRO Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Biopharmaceutical CMO & CRO Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Biopharmaceutical CMO & CRO Market Segmentation:
Biopharmaceutical CMO & CRO Market, By Type
- Mammalian
- Non-mammalian
- Other
Biopharmaceutical CMO & CRO Market, By Application
- Contract Manufacturing
- Contract Research
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Biopharmaceutical CMO & CRO market in terms of demand generation. The Biopharmaceutical CMO & CRO market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Biopharmaceutical CMO & CRO market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Biopharmaceutical CMO & CRO Market Taxonomy:
To learn more about this report
Global Biopharmaceutical CMO & CRO Market Competitive Landscape
The global Biopharmaceutical CMO & CRO market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Lonza
- Boehringer Ingelheim GmbH
- Rentschler Biotechnologie GmbH
- Inno Biologics Sdn Bhd
- JRS Pharma
- BIOMEVA GmbH
- ProBioGen
- FUJIFILM Diosynth Biotechnologies U.S.A.
- Inc.
- TOYOBO CO.
- LTD
- Samsung BioLogics
- Patheon
- CMC Biologics
- Binex Co.
- Ltd.
- AbbVie Inc.
- WuXi Biologics
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Mammalian, Non-mammalian, Other |
| By Application Outlook |
Contract Manufacturing, Contract Research, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Lonza, Boehringer Ingelheim GmbH, Rentschler Biotechnologie GmbH, Inno Biologics Sdn Bhd, JRS Pharma, BIOMEVA GmbH, ProBioGen, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., TOYOBO CO., LTD, Samsung BioLogics, Patheon, CMC Biologics, Binex Co., Ltd., AbbVie Inc., WuXi Biologics |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type (2017-2027)
1.4.2 Mammalian
1.4.3 Non-mammalian
1.5 Market by Application
1.5.1 Global Biopharmaceutical CMO & CRO Market Share by Application (2017-2027)
1.5.2 Contract Manufacturing
1.5.3 Contract Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biopharmaceutical CMO & CRO Market Size
2.2 Biopharmaceutical CMO & CRO Growth Trends by Regions
2.2.1 Biopharmaceutical CMO & CRO Market Size by Regions (2017-2027)
2.2.2 Biopharmaceutical CMO & CRO Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Biopharmaceutical CMO & CRO Market Size by Manufacturers
3.1.1 Global Biopharmaceutical CMO & CRO Revenue by Manufacturers (2017-2020)
3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Biopharmaceutical CMO & CRO Market Concentration Ratio (CR5 and HHI)
3.2 Biopharmaceutical CMO & CRO Key Players Head office and Area Served
3.3 Key Players Biopharmaceutical CMO & CRO Product/Solution/Service
3.4 Date of Enter into Biopharmaceutical CMO & CRO Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Biopharmaceutical CMO & CRO Market Size by Type (2017-2020)
4.2 Global Biopharmaceutical CMO & CRO Market Size by Application (2017-2020)
5 United States
5.1 United States Biopharmaceutical CMO & CRO Market Size (2017-2020)
5.2 Biopharmaceutical CMO & CRO Key Players in United States
5.3 United States Biopharmaceutical CMO & CRO Market Size by Type
5.4 United States Biopharmaceutical CMO & CRO Market Size by Application
6 Europe
6.1 Europe Biopharmaceutical CMO & CRO Market Size (2017-2020)
6.2 Biopharmaceutical CMO & CRO Key Players in Europe
6.3 Europe Biopharmaceutical CMO & CRO Market Size by Type
6.4 Europe Biopharmaceutical CMO & CRO Market Size by Application
7 China
7.1 China Biopharmaceutical CMO & CRO Market Size (2017-2020)
7.2 Biopharmaceutical CMO & CRO Key Players in China
7.3 China Biopharmaceutical CMO & CRO Market Size by Type
7.4 China Biopharmaceutical CMO & CRO Market Size by Application
8 Japan
8.1 Japan Biopharmaceutical CMO & CRO Market Size (2017-2020)
8.2 Biopharmaceutical CMO & CRO Key Players in Japan
8.3 Japan Biopharmaceutical CMO & CRO Market Size by Type
8.4 Japan Biopharmaceutical CMO & CRO Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Biopharmaceutical CMO & CRO Market Size (2017-2020)
9.2 Biopharmaceutical CMO & CRO Key Players in Southeast Asia
9.3 Southeast Asia Biopharmaceutical CMO & CRO Market Size by Type
9.4 Southeast Asia Biopharmaceutical CMO & CRO Market Size by Application
10 India
10.1 India Biopharmaceutical CMO & CRO Market Size (2017-2020)
10.2 Biopharmaceutical CMO & CRO Key Players in India
10.3 India Biopharmaceutical CMO & CRO Market Size by Type
10.4 India Biopharmaceutical CMO & CRO Market Size by Application
11 Central & South America
11.1 Central & South America Biopharmaceutical CMO & CRO Market Size (2017-2020)
11.2 Biopharmaceutical CMO & CRO Key Players in Central & South America
11.3 Central & South America Biopharmaceutical CMO & CRO Market Size by Type
11.4 Central & South America Biopharmaceutical CMO & CRO Market Size by Application
12 International Players Profiles
12.1 Lonza
12.1.1 Lonza Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biopharmaceutical CMO & CRO Introduction
12.1.4 Lonza Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.1.5 Lonza Recent Development
12.2 Boehringer Ingelheim GmbH
12.2.1 Boehringer Ingelheim GmbH Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biopharmaceutical CMO & CRO Introduction
12.2.4 Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.2.5 Boehringer Ingelheim GmbH Recent Development
12.3 Rentschler Biotechnologie GmbH
12.3.1 Rentschler Biotechnologie GmbH Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biopharmaceutical CMO & CRO Introduction
12.3.4 Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.3.5 Rentschler Biotechnologie GmbH Recent Development
12.4 Inno Biologics Sdn Bhd
12.4.1 Inno Biologics Sdn Bhd Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biopharmaceutical CMO & CRO Introduction
12.4.4 Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.4.5 Inno Biologics Sdn Bhd Recent Development
12.5 JRS Pharma
12.5.1 JRS Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biopharmaceutical CMO & CRO Introduction
12.5.4 JRS Pharma Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.5.5 JRS Pharma Recent Development
12.6 BIOMEVA GmbH
12.6.1 BIOMEVA GmbH Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biopharmaceutical CMO & CRO Introduction
12.6.4 BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.6.5 BIOMEVA GmbH Recent Development
12.7 ProBioGen
12.7.1 ProBioGen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biopharmaceutical CMO & CRO Introduction
12.7.4 ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.7.5 ProBioGen Recent Development
12.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
12.8.1 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biopharmaceutical CMO & CRO Introduction
12.8.4 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.8.5 FUJIFILM Diosynth Biotechnologies U.S.A., Inc. Recent Development
12.9 TOYOBO CO., LTD
12.9.1 TOYOBO CO., LTD Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biopharmaceutical CMO & CRO Introduction
12.9.4 TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.9.5 TOYOBO CO., LTD Recent Development
12.10 Samsung BioLogics
12.10.1 Samsung BioLogics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biopharmaceutical CMO & CRO Introduction
12.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2017-2020)
12.10.5 Samsung BioLogics Recent Development
12.11 Patheon
12.12 CMC Biologics
12.13 Binex Co., Ltd.
12.14 AbbVie Inc.
12.15 WuXi Biologics
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
